STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Launched by THE SOCIETY OF THORACIC SURGEONS · Nov 26, 2012
Trial Information
Current as of August 11, 2025
Recruiting
Keywords
ClinConnect Summary
The STS/ACC Transcatheter Valve Therapy Registry, also known as the TVT Registry, is studying a treatment called transcatheter aortic valve replacement (TAVR) for people with a condition called aortic valve stenosis, which makes it hard for the heart to pump blood. This registry is set up to collect information on patient safety and the outcomes of this procedure in real-life settings. It aims to help doctors and researchers understand how well TAVR works and to improve care for patients undergoing this treatment.
If you are 18 years or older and have aortic valve stenosis, you may be eligible to participate in this registry, which is currently recruiting participants. Those who join can expect to provide information about their health and treatment experiences, helping to ensure that this new procedure is safe and effective for everyone. This registry is an important step in improving heart valve treatments and ensuring that patients receive the best possible care.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • 18 years or older
About The Society Of Thoracic Surgeons
The Society of Thoracic Surgeons (STS) is a leading professional organization dedicated to advancing the field of thoracic surgery through research, education, and collaborative initiatives. Established to enhance the quality of patient care, STS fosters innovation in surgical practices and promotes evidence-based approaches to treatment. By sponsoring clinical trials, the Society aims to generate robust data that informs best practices, improves patient outcomes, and supports the continued professional development of thoracic surgeons. Through its commitment to excellence and collaboration, STS plays a pivotal role in shaping the future of cardiothoracic surgery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Patients applied
Trial Officials
John D Carroll, MD
Principal Investigator
American College of Cardiology
Fred H Edwards, MD
Principal Investigator
Society of Thoracic Surgeons
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials